Dr. Deborah Marshall

Biography

Dr. Deborah A Marshall is the Arthur J.E. Child Chair of Rheumatology Outcomes Research and former Canada Research Chair, Health Services and Systems Research (2008-2018). In addition, she is a member of the McCaig Institute of Bone and Joint Health, O’Brien Institute of Public Health, Alberta Children’s Hospital Research institute (ACHRI), and a Senior Scientist at Arthritis Research Canada.

Dr. Marshall’s research programme is focused on assessing the value of health care interventions through measurement of patient preferences, cost-effectiveness analysis, and simulation modeling of health care delivery systems in the context of precision medicine and patient engagement and patient centeredness. She is a founding co-investigator of the innovative Patient and Community Engagement Research (PaCER) Program at the University of Calgary which trains patients to design and conduct health research, using specific adapted methods of qualitative inquiry. She has experience in technology assessment agencies, academia and pharmaceutical and diagnostics industry research settings in Canada, the United States, and Europe.

Dr. Marshall co-leads the health economics, patient preferences and patient engagement activities for 3 large national and international research programmes in precision medicine: 1) UCAN CAN DU (Canada-Netherlands personalized medicine network in childhood arthritis and rheumatic disease, CIHR/Genome Canada); 2) UCAN CURE (Precision Decisions for Childhood Arthritis, CIHR/Genome Canada); 3) SOLVE (Care4Rare Canada: Harnessing multi-omics to deliver innovative diagnostic care for rare genetic diseases in Canada). Dr. Marshall is also the co-lead of the Patient Engagement theme for IMAGINE (Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects) – a CIHR Strategy for Patient Oriented Research (SPOR) Chronic Disease Network.

Biography continued

Dr. Marshall is an active member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the Past President of the Board of Directors, the Chair of the Dynamic Simulation Modeling Applications in Health Care Delivery Research Task Force and as a member of the Patient Preferences Special Interest Group, the Optimization Methods Task Force and co-author of related ISPOR Task Force Reports. She has also served as a member of the Board of Directors for Health Technology Assessment International (HTAi). She is the former co-chair of the Scientific Research Committee and member of the Board of Directors of the Arthritis Alliance of Canada (AAC), and a member of the Scientific Advisory Committee of the Alberta PROMs & EQ-5D Research & Support Unit (APERSU).

Education and Training

Ph.D., School of Public Health, University of North Carolina; M.H.S.A, University of Alberta; BSc(Hons) University of Toronto

Research Interests and Expertise

Patient preferences using stated preferences methods in health care applications.
Care pathway and health system modeling using dynamic simulation modeling as a health services planning tool.
Economic evaluation of health care programmes using decision analysis and simulation methods, particularly cost effectiveness of testing and treatment interventions in personalised medicine.
Tools to inform personalized decision making in health

Contact

damarsha@ucalgary.ca

https://profiles.ucalgary.ca/deborah-marshall

Key Publications

Mazzei DR, Whittaker JL, Kania-Richmond A, Faris P, Wasylak T, Robert J, Hawker G, Marshall DA, Do people with knee osteoarthritis use guideline-consistent treatments after an orthopaedic surgeon recommends nonsurgical care? A cross-sectional survey with long-term follow-up, Osteoarthritis and Cartilage Open, March (2022 (doi: https://doi.org/10.1016/j.ocarto.2022.100256) (in press)

Hawker GA, Bohm E, Dunbar MJ, Jones CA, Noseworthy T, Marshall DA, BEST-Knee Study Team. The effect of patient age and surgical appropriateness and their influence on surgeon recommendations for primary TKA: A cross-sectional study of 2,037 patients. JBJS, Feb 2022 (doi: 10.2106/JBJS.21.00597)

Marshall DA, Barker K, Rines J, et al. A patient-led, peer-to-peer qualitative study on the psychosocial relationship between young adults with inflammatory bowel disease and food. Health Expectations, March 2022. (Grant # associated: IMAGINE Grant, 1715‐000‐001)

Mirza R, MacKean G, Shaffer S, Sewitch M, Heisler CG, McLeod J, Habashi P, MacDonald K, Barker K, Nguyen G, Marshall DA. Eliciting Patient Perspectives in the Management of Inflammatory Bowel Disease: A Qualitative Study. Journal of the Canadian Association of Gastroenterology, March 2022 (in press)

Sewitch M, Harvey E, El Bizri M, Nguyen G, Marshall DA, Mirza R. Health care perspectives of adult patients with lower educational attainment in inflammatory bowel disease: A qualitative study. Journal of Patient Experience, March 2022 (in press).

A, Emery CA, MacKean G, Marshall DA. Factors That Patients Consider in Their Choice of Non-Surgical Management for Hip and Knee Osteoarthritis: Formative Qualitative Research for a Discrete Choice Experiment. The Patient -- Patient-Centered Outcomes Research, March 2022. https://doi.org/10.1007/s40271-022-00577-9 (in press)

Kennedy BL, Currie GR, Kania-Richmond A, Emery CA, MacKean G, Marshall DA. Patient beliefs about who and what influences their hip and knee osteoarthritis symptoms and progression. Musculoskeletal Care, Feb 2022; (in press) https://doi.org/10.1002/msc.1620

Currie GR, Pham T, Twilt M, Ijzerman MJ, Hull PM, Kip MMA, Benseler S, Hazlewood GS, Yeung R,Wulffraat N, Swart JF, Vastert SJ, Marshall DA. Perspectives of pediatric rheumatologists on initiating and tapering biologics in patients with Juvenile Idiopathic Arthritis: A formative qualitative study. The Patient - Patient-Centered Outcomes Research. Feb 2022 (in press). https://doi.org/10.1007/s40271-022-00575-x

Kip MMA, de Roock S, van den Berg I, Currie G, Marshall DA, Grazziotin LR, Twilt M, Yeung RSM, Benseler SM, Vastert SJ, Wulffraat N, Swart JF, IJzerman MJ. Costs of hospital-associated care for patients with juvenile idiopathic arthritis in the Dutch healthcare system. Arthritis Care Res, May 2021 (doi: 10.1002/acr.24621). (in press)

Hawker GA, Conner-Spady BL, Bohm E, Dunbar MJ, Jones CA, Ravi B, Noseworthy T, Woodhouse LJ, Faris P, Dick D, Powell J, Paul P, Marshall DA; BEST-Knee Study Team. The Relationship between Patient-Reported Readiness for Total Knee Arthroplasty and Likelihood of a Good Outcome at One Year (Revision). Arthritis Care & Research (Hoboken), Jan 2021. (doi: 10.1002/acr24562) (in press)

PUBLISHED:

Hazlewood GS, Loyola-Sanchez A, Bykerk V, Hull PM, Marshall DA, Pham T, Barber CEH, Barnabe C, Sirois A, Pope J, Schieir O, Richards D, Proulx L, Bartlett S. Patient and Rheumatologist Perspectives on Tapering DMARDs in Rheumatoid Arthritis: A Qualitative Study. Rheumatology (Oxford). Feb 2022;61(2):606-616.

Currie GR, Lee R, Black AM, Palacios-Derflingher L, Hagel BE, Emery CA, Marshall DA. An economic evaluation of disallowing body checking in 11- to 12-year-old ice hockey leagues. Sports Health. Feb 2022;14(2):293-298.

Hazlewood GS, Bombardier C, Li X, Moyahedi M, Coquette D, Coupal L, Bykerk VP, Schieir O, Mosher D, Marshall DA, Bernatsky S, Spencer N, Richards DP, Proulx L, Barber CEH, OBRI, Rhumdata,CATCH Investigators, the Rheu4U Team. Heterogeneity in patient characteristics and differences in treatment across 4 Canadian rheumatoid arthritis cohorts. Journal of Rheumatology, Jan 2022;49(1):16-25.

Gupta A, Cafazzo JA, IJzerman MJ, Swart JF, Vastert S, Wulffraat NM, Benseler S, Marshall DA, Yeung R, Twilt M. Genomic Health Literacy Interventions in Pediatrics: A Scoping Review to Inform Digital Health Interventions. JMIR, Dec 2021;23(12):e26684.

Hayeems R, Michaels Igbokwe C, Venkataramanan V, Hartley T, Acker M, Gillespie M, Ungar W, Mendoza-Londona R, Bernier FP, Boycott K, Marshall DA. The complexity of diagnosing rare disease: An organising framework for outcomes research and health economics based on real world evidence. Genetics in Medicine, Dec 2021;S1098-3600(21):05383-1

Benham JL, Atabati O, Oxoby RJ, Mourali M, Shaffer B, Fullerton MM, Tang T, Sheikh H, Constantinescu C, Manns BJ, Marshall DA, Ivers NM, Ratzan SC, Hu J, Lang R. COVID-19 vaccine-related attitudes and beliefs in Canada: National cross-sectional survey and cluster analysis. JMIR Public Health Surveill. Dec 2021;7(12)e30424.

Shewchuk B, Green LA, Barber T, Miller J, Teare S, Campbell-Scherer D, Mrklas KJ, Li LC, Marlett N, Wasylak T, Lopatina E, McCaughey D, Marshall DA. Patients’ use of mHealth for self-management of knee osteoarthritis: results of a 6-week pilot study. JMIR Formative Research, Nov 2021;5(11):e30495.

Michaels-Igbokwe C, Currie G, Kennedy BL, MacDonald KV, Marshall DA. Methods for conducting stated preference research with children and adolescents in health: A scoping review of the application of discrete choice experiments. The Patient – Patient-Centered Outcomes Resarch, Nov 2021;14(6):741-758.

Lang R, Atabati O, Oxoby RJ, Mourali M, Shaffer B, Sheikh H, Fullerton MM, Tang T, Parsons Leigh J, Manns BJ, Marshall DA, Ivers NM, Ratzan SC, Hu J, Benham JL. Characterization of non-adopters of COVID-19 non-pharmaceutical interventions through a national cross-sectional survey to assess attitudes and behaviours. Scientific Reports, Nov 2021;11:21751.

Tagimacruz T, Bischak DP, Marshall DA. Alternative care providers in rheumatoid arthritispatient care: a queueing and simulation analysis. Health Systems, Nov 2021;10(4):249-267.

Marshall DA, Jin X, Pittman LB, Smith CJ. The use of patient-reported outcome measures in hip and knee arthroplasty in Alberta. BMC Supplements JPRO, Oct 2021;5(Suppl2):87

Gonzalez Sepulveda JM, Johnson FR, Marshall DA. Incomplete Information and Irrelevant Attributes in Stated-Preference Values for Health Interventions. Health Economics, Nov 2021;30(11):2637-2648 (Grant # associated with artile: R01 HG007063)

Hawker GA, Conner-Spady BL, Bohm E, Dunbar MJ, Jones A, Ravi B, Noseworthy T, Faris P, Dick D, Powell J, Paul P, Marshall DA, BEST-Knee Study Team. Reply to Letter to the Editor – Concerns regarding p-value-based variable selection of exposure variables and confounding factors: Comment on the Article by Hawker et al. Arthritis Rheumatology, Oct 2021;73(10):1946-1947.

Kip MMA, de Roock S, Currie G, Marshall DA, Grazziotin LR, Twilt M, Yeung RSM, Benseler SM, Schreijer MA, Vastert SJ, Wulffraat N, van Royen-Kerkhof A, Swart JF, IJzerman MJ. Costs of medication use among patients with juvenile idiopathic arthritis in the Dutch healthcare system. Expert Review of Pharmacoeconomics & Outcomes Research, Oct 2021;21(5):975-984.

Lacny SL, Faris P, Bohm E, Woodhouse LJ, Robertsson O, Marshall DA. Competing risks methods are recommended for estimating the cumulative incidence of revision arthroplasty for health care planning purposes. Orthopedics. Aug 2021;44(4):e549-e555.

Thomas M, Fraenkel L, Boonen A, Bansback N, Buchbinder R, Marshall DA, Proulx L, Voshaar M, Richards P, Richards DP, Hiligsmann M, Guillemin F, Shea B, Tugwell P, Hazlewood G. Patient preferences to value health outcomes in rheumatology clinical trials: Report from the OMERACT special interest group. Seminars in Arthritis and Rheumatism. Aug 2021;51(4):919-924.

Lopatina E, Marshall DA, Le Clercq SA, Noseworthy TW, Suter E, De la Rosa Jaimes C, Lauf AM, Mosher DP, Barber CEH. Nurse-led care for stable patients with rheumatoid arthritis: quality of care in routine practice compared to the traditional rheumatologist-led model. Rheumatology and Therapy Journal (Open Access). Sept 2021;8(3):1263-1285.

Grazziotin LR, Currie G, Twilt M, Ijzerman MJ, Kip MMA, Koffijberg H, Benseler SM, Swart JF, Vastert SJ, Wulffraat NM, Yeung RSM, Johnson N, Luca NJ, Miettunen PM, Schmeling H, Marshall DA. Evaluation of real-world healthcare resource utilization and associated costs in children with Juvenile Iodiopathic Arthritis: A Canadian retrospective cohort study. Rheumatology and Therapy. Sept 2021;8(3):1303-1322.

Boucher JC, Cornelson K, Benham JL, Fullerton MM, Tang T, Constantinescu C, Mourali M, Oxoby RJ, Marshall DA, Hemmati H, Badami A, Hu J, Lang R. Analyzing Social Media to Explore the Attitudes and Behaviors Following the Announcement of Successful COVID-19 Vaccine Trials: Infodemiology Study. JMIR Infodemiology Aug 2021;1(1):e28800

Barber CEH, Lacaille D, Faris P, Mosher D, Katz S, Patel JN, Zhang S, Yee K, Barnabe C, Hazlewood GS, Bykerk V, Shiff NJ, Twilt M, Burt J, Benseler SM, Homik J, Marshall DA. Evaluating quality of care for rheumatoid arthritis for the population of Alberta using system-level performance measures. Journal of Rheumatology, April 2021;48(4):482-485.

Barber CEH, Lacaille D, Hall M, Bohm V, Li LC, Barnabe C, Hazlewood GS, Marshall DA, Rankin JA, Tsui K, English K, MacMullan P, Homik J, Mosher D, Then KL. Priorities for High Quality Care in Rheumatoid Arthritis: Results of Patient, Health Professional, and Policymaker Perspectives. Journal of Rheumatology, April 2021;48(8):486-494.

Currie GR, Lee R, Palacios-Derflingher L, Hagel B, Black AM, Babul S, Mrazik M, Marshall DA, Emery CA. Reality Check 2: The cost-effectiveness of policy disallowing body checking in non-elite 13 -to 14-year-old ice hockey players. IJERPH, June 2021; 18(12):6322

King LK, Waugh EJ, Jones CA, Bohm E, Dunbar M, Woodhouse L, Noseworthy T, Marshall DA, Hawker GA; BEST-Knee Team. Comorbidities Do Not Limit Improvement in Pain and Physical Function After Total Knee Arthroplasty in Patients with Knee Osteoarthritis: The BEST-Knee Prospective Cohort Study. BMJ Open, June 2021;11(6):e047061.

Barber CEH, Marshall DA, Szefer E, Barnabe C, Shiff NJ, Bykerk V, Homik J, Thorne JC, Ahluwalia V, Benseler S, Mosher D, Twilt M, Lacaille D. A population-based approach to reporting system-level performance measures for rheumatoid arthritis care. Arthritis Care & Research (Hoboken), May 2021;73(5):640-648.

Lang R, Benham JL, Atabati O, Hollis A, Tombe T, Shaffer B, Kovacs Burns K, MacKean G, Léveillé T, McCormack B, Sheikh H, Fullerton MM, Tang T, Boucher JC, Constantinescu C, Mourali M, Manns BJ, Marshall DA, Hu J, Oxoby RJ. Attitudes, behaviours and barriers to public health measures for COVID-19: a survey to inform public health messaging. BMC Public Health, Open Acess, April 2021;21(1):765.

Liu X, Barber, CEH, Katz, S, Homik J, Bertazzon S, Patel AB, Robert J, Smith C, Mosher D, Marshall DA. Geographic Variation in the Prevalence of Rheumatoid Arthritis in Alberta, Canada. ACR Open Rheumatology. March 2021;3(5):324-332 (https://doi.org/10.1002/acr2.11251)

Barber C, Lacaille D, Hall M, Bohm V, Li LC, Barnabe C, Rankin J, Hazlewood G, Marshall DA, Macmullan P, Mosher D, Homik J, English K, Tsu K, Then KL. Strategies for Developing and Implementing a Rheumatoid Arthritis Healthcare Quality Framework: A Thematic Analysis of Perspectives from Arthritis Stakeholders. BMJ Open. March 2021;11(3):e043759.

Benham JL, Lang R, Kovacs Burns K, MacKean G, Leveille T, McCormack B, Sheikh H, Fullerton MM, Tang T, Boucher JC, Constantinescu C, Mourail M, Oxoby RJ, Manns BJ, Hu J, Marshall DA. Attitudes, current behaviours and barriers to public health measures that reduce COVID-19 transmission: A qualitative study to inform public health messaging. PLoS One, Feb 2021;16(2):e0246941.

Michaels-Igbokwe C, McInnes B, MacDonald KV, Currie GR, Omar F, Shewchuk B, Bernier FP, Marshall DA. (Un)standardized testing: the diagnostic odyssey of children with rare genetic disorders in Alberta, Canada. Genetics Medicine, Feb 2021;23(2):272-279.

Hawker GA, Connor-Spady BL, Bohm E, Dunbar MJ, CA Jones, Ravi B, Noseworthy T, Dick D, Powell J, Paulose P, Marshall DA. Patients’ Preoperative Expectations of Total Knee Arthroplasty and Satisfaction with Outcomes at One Year: A Prospective Cohort Study. Arthritis and Rheumatology, Feb 2021;73(2):223-231.

Phillips KA, Douglas MP, Wordsworth S, Buchanan J, Marshall DA. Availability and funding of clinical genomic sequencing globally. BMJ Global Health, Jan 2021;6:e004415.

Lopatina E, Marshall DA, Coupal L, Le Lorier J, Choquette D. Cost-utility analysis of second-line therapy with rituximab compared to tumour necrosis factor inhibitors in rheumatoid arthritis. Current Medical Research and Opinion, Jan 2021;37(1):157-166.

Barber CEH, Then KL, Bohm V, Hall M, Marshall DA, Rankin JA, Barnabe C, Hazlewood GS, Li LC, Mosher D, Homik J, MacMullan P, Tsui K, English K, Lacaille D for RA Quality Measurement Delphi Panel Group. Development of a patient- centered quality measurement framework for measuring, monitoring and optimizing rheumatoid arthritis care in Canada. Journal of Rheumatology, Jan 2021;48(3):326-334.

Barber CEH, Mosher D, Dowling S, Bohm V, Solbak NM, MacMullan P, Pan B, Barnabe C, Hazlewood GS, Then KL, Marshall DA, Rankin JA, Li LC, Tsui K, English K, Homik J, Spencer N, Hall M, Lacaille D. Implementation and Evaluation of Audit and Feedback for Monitoring Treat-to-Target (T2T) Strategies in Rheumatoid Arthritis Using Performance Measures. Rheumatol Ther, Dec 2020;7:909-925.

Phillips KA, Douglas MP, Marshall DA. Expanding Use of Clinical Genome Sequencing and the Need for More Data on Implementation. JAMA Nov 2020;324(20):2029-2030.

Mazzei DR, Ademola A, Abbott JH, Sajobi T, Hildebrand K, Marshall DA. Are Education, Exercise and Diet Interventions A Cost-Effective Treatment to Manage Hip and Knee Osteoarthritis? A Systematic Review. Osteoarthritis and Cartilage, Nov 2020; S1063 – 4584 (20) 31165-1.

Moayyedi P, MacQueen G (post-humous), Bernstein CN, Vanner S, Bercik P, Madsen KL, Surette M, Rioux JD, Dieleman LA, Verdl E, De Souza RJ, Otley A, Targownik L, Lavis J, Cunningham J, Marshall DA, Zelinsky S, Fernandes A. IMAGINE Network’s Mind And Gut Interactions Cohort (MAGINE) Study: A protocol for a prospective observational multicentre cohort study in inflammatory bowel disease and irritable bowel syndrome. BMJ Open, Oct 2020;10(10):e041733.

Liu X, Shahid R, Patel AB, McDonald T, Bertzzon S, Waters N, Seidel JE, Marshall DA. Geospatial patterns of comorbidity prevalence among people with osteoarthritis in Alberta Canada. BMC Public Health, Oct 2020;20(1):1551.

Mazzei DR, Ademola A, Abbott JH, Sajobi T, Hildebrand K, Marshall DA. Systematic review of economic evaluations investigating education, exercise and dietary weight management to manage hip and knee osteoarthritis: Protocol. Systematic Reviews, Oct 2020;9(1):299-306

Carr ECJ, Ortiz MM, Patel JN, Barber CEH, Katz S, Robert J, Mosher D, Teare SR, Miller J, Homik J, Dinsmore K, Marshall DA. Models of arthritis care: A systems-level evaluation of acceptability as a dimension of quality care. J Rheumatology. Sept 2020;47(9):1431-1439.

King LK, Marshall DA, Jones CA, Woodhouse LJ, Ravi B, Faris PD, Hawker GA; BEST-Knee Team. Are medical comorbidities contributing to the use of opioid analgesics in patients with knee osteoarthritis? Osteoarthritis Cartilage. 2020 Aug;28(8):1030-1037.

King LK, Marshall DA, Faris P, Woodhouse LJ, Jones CA, Noseworthy T, Bohm E, Dunbar MJ, Hawker GA, BEST-Knee Research Team. Use of recommended non-surgical knee osteoarthritis management in patients prior to total knee arthroplasty: A cross-sectional study. J of Rheumatology. Aug 2020; 47(8):1253-1260.

Grazziotin LR, Dada BR, de la Rosa Jamies C, Cheung WY, Marshall DA. Chromogenic and silver in situ hybridization for identification of HER 2 overexpression in breast cancer patients: a systematic review and meta-analysis. Applied Immunohistochemistry & Molecular Morphology. July 2020;28(6):411-421.

Grazziotin LR, Currie G, Kip MMA, Ijzerman MJ, Twilt M, Lee R, Marshall DA. Health State Utility Values in Juvenile Idiopathic Arthritis: What is the Evidence? Pharmacoeconomics. Sept 2020; 38(9):913-926.

Marshall DA, Pham T, Faris P, Chen G, O’Donnell S, Barber CEH, LeClercq S, Katz S, Homik J, Patel JN, Lopatina E, Roberts J, Mosher D. Determination of Rheumatoid Arthritis Incidence and Prevalence in Alberta using Administrative Health Data. ACR Open a Rheumatology, June 2020; 2(7):424-429.

Mrklas KJ, Barber T, Campbell-Scherer D, Green LA, Li LC, Marlett N, Miller J, Shewchuk B, Teare S, Wasylak T, Marshall DA. Co-Design in the Development of a Mobile Health App for the Management of Knee Osteoarthritis by Patients and Physicians: Qualitative Study. JMIR Mhealth Uhealth. July 2020;8(7):e17893.

Hazlewood GS, Marshall DA, Barber CEH, Li LC, Barnabe C, Bykerk V, Tugwell P, Hull PM, Bansback N. Using a discrete-choice experiment in a decision aid to nudge patients towards value-concordant treatment choices in rheumatoid arthritis: A proof-of-concept study. Patient Preference and Adherence. May 2020;14:829-838.

Marshall DA, Grazziotin LR, Regier DA, Wordsworth S, Buchanan J, Phillips K, Ijzerman M. Addressing challenges of economic evaluation in precision medicine using dynamic simulation modelling. Value in Health, May 2020;23(5):566-573.

Malone DC, Ramsey SD, Patrick DL, Johnson FR, Mullins CD, Roberts MS, Willke RJ, Marshall DA. Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report. Value in Health, April 2020;23(4): 409-415.

Barber CEH, Twilt M, Pham T, Currie GR, Benseler S, Yeung RSM, Batthish M, Blanchette N, Guzman J, Lang B, LeBlanc C, Levy DM, O’Brien C, Schmeling H, Soon G, Spiegel L, Whitney K, Marshall DA. A Canadian evaluation framework for quality improvement in childhood arthritis: key performance indicators of the process of care. Arthritis Research and Therapy, March 2020;22(1):53.

Hazlewood GS, Pokharel G, Deardon R, Marshall DA, Bombardier C, Tomlinson G, Ma C, Seow CH, Panaccione R, Kaplan G. Patient preferences for maintenance therapy in Crohn's disease: A discrete-choice experiment. PLoS One, Jan 2020;15(1): e0227635

Loyola-Sanchez A, Hazlewood G, Crowshoe L, Linkert T, Hull PM, Marshall DA, Barnabe C. Qualitative study of treatment preferences for rheumatoid arthritis and pharmacotherapy acceptance: Indigenous patient perspectives. Arthritis Care Research (Hoboken), April 2020;72(4):544-552.

Conner-Spady BL, Bohm E, Loucks L, Dunbar MJ, Marshall DA, Noseworthy TW. Patient expectations and satisfaction 6 and 12 months following total hip and knee replacement. Quality of Life Research, March 2020;29(3):705-719.

Durand C, Maysoon E, Marshall DA, Bansback N, Hazlewood GS. Patient preferences for disease-modifying antirheumatic drug treatment in in rheumatoid arthritis: A systematic review. Journal of Rheumatology, Feb 2020;47(2):176-187.